Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2757-2768

  Han, Tao ^a   Wan, Yushun ^a   Wang, Jun ^a   Zhao, Peng ^a   Yuan, Yue ^a   Wang, Li ^a   She, Yinglong ^a   Broering, Ruth ^b   Lu, Mengji ^c   Ye, Linbai ^a   Zhu, Ying ^a  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; HISTONE LYSINE METHYLTRANSFERASE; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 37; JANUS KINASE; PROTEIN IFNAR1; PROTEIN IFNAR2; PROTEIN KINASE R; PROTEIN SET7; STAT1 PROTEIN; STAT2 PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ALPHA INTERFERON; SETD7 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS ATTENUATION; VIRUS REPLICATION; CELL LINE; CHRONIC HEPATITIS; GENE EXPRESSION; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LIVER CELL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS, CHRONIC; HEPATOCYTES; HISTONE-LYSINE N-METHYLTRANSFERASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84924533794     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400583     Document Type: Article

References (65)

1. Casey, L. C., and W. M. Lee. 2013. Hepatitis C virus therapy update 2013. Curr. Opin. Gastroenterol. 29: 243-249.
2. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362.
3. Bartenschlager, R., and V. Lohmann. 2000. Replication of hepatitis C virus. J. Gen. Virol. 81: 1631-1648.
4. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q. L. Choo. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14: 381-388.
5. Penin, F., J. Dubuisson, F. A. Rey, D. Moradpour, and J. M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39: 5-19.
6. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8: 559-568.
7. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
8. Moradpour, D., and H. E. Blum. 1999. Current and evolving therapies for hepatitis C. Eur. J. Gastroenterol. Hepatol. 11: 1199-1202.
9. Nitta, S., N. Sakamoto, M. Nakagawa, S. Kakinuma, K. Mishima, A. Kusano-Kitazume, K. Kiyohashi, M. Murakawa, Y. Nishimura-Sakurai, S. Azuma, et al. 2013. Hepatitis C virus NS4B protein targets STING and abrogates RIG-Imediated type I interferon-dependent innate immunity. Hepatology 57: 46-58.
10. Foy, E., K. Li, R. Sumpter, Jr., Y. M. Loo, C. L. Johnson, C. Wang, P. M. Fish, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102: 2986-2991.
11. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. Lai. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285: 107-110.
12. Gale, M. J., Jr., M. J. Korth, N. M. Tang, S. L. Tan, D. A. Hopkins, T. E. Dever, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230: 217-227.
13. Li, K., E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon, M. Ikeda, S. C. Ray, M. Gale, Jr., and S. M. Lemon. 2005. Immune evasion by hepatitis C virus NS3/ 4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102: 2992-2997.
14. Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
15. Dillon, S. C., X. Zhang, R. C. Trievel, and X. Cheng. 2005. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 6: 227.
16. Martin, C., and Y. Zhang. 2005. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 6: 838-849.
17. Li, Y., M. A. Reddy, F. Miao, N. Shanmugam, J. K. Yee, D. Hawkins, B. Ren, and R. Natarajan. 2008. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kB-dependent inflammatory genes. Relevance to diabetes and inflammation. J. Biol. Chem. 283: 26771-26781.
18. Wang, H., R. Cao, L. Xia, H. Erdjument-Bromage, C. Borchers, P. Tempst, and Y. Zhang. 2001. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol. Cell 8: 1207-1217.
19. Nishioka, K., S. Chuikov, K. Sarma, H. Erdjument-Bromage, C. D. Allis, P. Tempst, and D. Reinberg. 2002. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 16: 479-489.
20. Wilson, J. R., C. Jing, P. A.Walker, S. R. Martin, S. A. Howell, G. M. Blackburn, S. J. Gamblin, and B. Xiao. 2002. Crystal structure and functional analysis of the histone methyltransferase SET7/9. Cell 111: 105-115.
21. Veerappan, C. S., Z. Avramova, and E. N. Moriyama. 2008. Evolution of SETdomain protein families in the unicellular and multicellular Ascomycota fungi. BMC Evol. Biol. 8: 190.
22. Dhayalan, A., S. Kudithipudi, P. Rathert, and A. Jeltsch. 2011. Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem. Biol. 18: 111-120.
23. Kim, H. J., J. H. Seol, J. W. Han, H. D. Youn, and E. J. Cho. 2007. Histone chaperones regulate histone exchange during transcription. EMBO J. 26: 4467-4474.
24. Keating, S. T., and A. El-Osta. 2013. Transcriptional regulation by the Set7 lysine methyltransferase. Epigenetics 8: 361-372.
25. Xiao, B., C. Jing, J. R. Wilson, P. A. Walker, N. Vasisht, G. Kelly, S. Howell, I. A. Taylor, G. M. Blackburn, and S. J. Gamblin. 2003. Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 421: 652-656.
26. Hsu, C. H., K. L. Peng, H. C. Jhang, C. H. Lin, S. Y. Wu, C. M. Chiang, S. C. Lee, W. C. Yu, and L. J. Juan. 2012. The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene 31: 2335-2349.
27. Chen, C., D. Pan, A. M. Deng, F. Huang, B. L. Sun, and R. G. Yang. 2013. DNA methyltransferases 1 and 3B are required for hepatitis C virus infection in cell culture. Virology 441: 57-65.
28. Pagans, S., S. E. Kauder, K. Kaehlcke, N. Sakane, S. Schroeder, W. Dormeyer, R. C. Trievel, E. Verdin, M. Schnolzer, and M. Ott. 2010. The cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 7: 234-244.
29. Shan, Z., Q. Han, J. Nie, X. Cao, Z. Chen, S. Yin, Y. Gao, F. Lin, X. Zhou, K. Xu, et al. 2013. Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation. J. Biol. Chem. 288: 35093-35103.
30. Liu, S., Q. Hao, N. Peng, X. Yue, Y. Wang, Y. Chen, J. Wu, and Y. Zhu. 2012. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology 56: 57-66.
31. Liu, X., D. Wang, Y. Zhao, B. Tu, Z. Zheng, L. Wang, H. Wang, W. Gu, R. G. Roeder, and W. G. Zhu. 2011. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc. Natl. Acad. Sci. USA 108: 1925-1930.
32. Zhang, Q., R. Gong, J. Qu, Y. Zhou, W. Liu, M. Chen, Y. Liu, Y. Zhu, and J. Wu. 2012. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway. J. Virol. 86: 1544-1554.
33. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102: 9294-9299.
34. Lemaire-Ewing, S., A. Berthier, M. C. Royer, E. Logette, L. Corcos, A. Bouchot, S. Monier, C. Prunet, M. Raveneau, C. Rébé, et al. 2009. 7b-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent. Cell Biol. Toxicol. 25: 127-139.
35. Hassan, M., H. Ghozlan, and O. Abdel-Kader. 2005. Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 333: 324-336.
36. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wölk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
37. Tscherne, D. M., C. T. Jones, M. J. Evans, B. D. Lindenbach, J. A. McKeating, and C. M. Rice. 2006. Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 80: 1734-1741.
38. Pradhan, S., H. G. Chin, P. O. Estève, and S. E. Jacobsen. 2009. SET7/9 mediated methylation of non-histone proteins in mammalian cells. Epigenetics 4: 383-387.
39. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Kräusslich, M. Mizokami, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11: 791-796.
40. Wang, C., J. Pflugheber, R. Sumpter, Jr., D. L. Sodora, D. Hui, G. C. Sen, and M. Gale, Jr. 2003. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77: 3898-3912.
41. Han, J. Q., and D. J. Barton. 2002. Activation and evasion of the antiviral 29-59 oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 8: 512-525.
42. Liu, W. L., W. C. Su, C. W. Cheng, L. H. Hwang, C. C. Wang, H. L. Chen, D. S. Chen, and M. Y. Lai. 2007. Ribavirin up-regulates the activity of doublestranded RNA-activated protein kinase and enhances the action of interferon-a against hepatitis C virus. J. Infect. Dis. 196: 425-434.
43. Taguchi, T., M. Nagano-Fujii, M. Akutsu, H. Kadoya, S. Ohgimoto, S. Ishido, and H. Hotta. 2004. Hepatitis C virus NS5A protein interacts with 29,59-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J. Gen. Virol. 85: 959-969.
44. Tokumoto, Y., Y. Hiasa, N. Horiike, K. Michitaka, B. Matsuura, R. T. Chung, and M. Onji. 2007. Hepatitis C virus expression and interferon antiviral action is dependent on PKR expression. J. Med. Virol. 79: 1120-1127.
45. National Institutes of Health. 2002. National Institutes of Health Consensus Development Conference statement: management of hepatitis C: 2002-June 10-12, 2002. Hepatology 36(5, Suppl. 1): S3-S20.
46. Pawlotsky, J. M. 2004. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 12: 96-102.
47. Yang, X. D., B. Huang, M. Li, A. Lamb, N. L. Kelleher, and L. F. Chen. 2009. Negative regulation of NF-kB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J. 28: 1055-1066.
48. Hu, H. Y., K. P. Li, X. J. Wang, Y. Liu, Z. G. Lu, R. H. Dong, H. B. Guo, and M. X. Zhang. 2013. Set9, NF-kB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol. Sin. 34: 157-166.
49. Guo, J. T., V. V. Bichko, and C. Seeger. 2001. Effect of a interferon on the hepatitis C virus replicon. J. Virol. 75: 8516-8523.
50. Frese, M., T. Pietschmann, D. Moradpour, O. Haller, and R. Bartenschlager. 2001. Interferon-a inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J. Gen. Virol. 82: 723-733.
51. Hoofnagle, J. H., and A. M. di Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336: 347-356.
52. Pawlotsky, J. M. 2013. Treatment of chronic hepatitis C: current and future. Curr. Top. Microbiol. Immunol. 369: 321-342.
53. Staeheli, P. 1990. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38: 147-200.
54. Murray, P. J. 2007. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178: 2623-2629.
55. Harrison, D. A. 2012. The JAK/STAT pathway. Cold Spring Harb. Perspect. Biol. 4: 4.
56. Lutfalla, G., S. J. Holland, E. Cinato, D. Monneron, J. Reboul, N. C. Rogers, J. M. Smith, G. R. Stark, K. Gardiner, K. E. Mogensen, et al. 1995. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14: 5100-5108.
57. Dondi, E., E. Pattyn, G. Lutfalla, X. Van Ostade, G. Uzé, S. Pellegrini, and J. Tavernier. 2001. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase. J. Biol. Chem. 276: 47004-47012.
58. Datta, S., S. Hazari, P. K. Chandra, M. Samara, B. Poat, F. Gunduz, W. C. Wimley, H. Hauser, M. Koster, C. Lamaze, et al. 2011. Mechanism of HCV's resistance to IFN-a in cell culture involves expression of functional IFN-a receptor 1. Virol. J. 8: 351.
59. Colamonici, O. R., and P. Domanski. 1993. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J. Biol. Chem. 268: 10895-10899.
60. Lu, L., L. Wei, G. Peng, Y. Mu, K. Wu, L. Kang, X. Yan, Y. Zhu, and J. Wu. 2008. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology 371: 61-70.
61. Litt, M. D., M. Simpson, M. Gaszner, C. D. Allis, and G. Felsenfeld. 2001. Correlation between histone lysine methylation and developmental changes at the chicken b-globin locus. Science 293: 2453-2455.
62. Noma K, C. D., C. D. Allis, and S. I. Grewal. 2001. Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science 293: 1150-1155.
63. de Lucas, S., J. Bartolome, and V. Carreno. 2005. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. J. Infect. Dis. 191: 93-99.
64. Zhang, L., H. J. Alter, H.Wang, S. Jia, E.Wang, F. M. Marincola, J.W. Shih, and R. Y. Wang. 2013. The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon b response in Huh7.5.1 cells. Virology 438: 28-36.
65. Ea, C. K., and D. Baltimore. 2009. Regulation of NF-kB activity through lysine monomethylation of p65. Proc. Natl. Acad. Sci. USA 106: 18972-18977.